DocuSign To Rally Around 25%? Here Are 10 Other Analyst Forecasts For Tuesday

  • Wells Fargo cut the price target for Cheniere Energy, Inc. LNG from $236 to $230. Wells Fargo analyst Michael Blum maintained an Overweight rating. Cheniere Energy shares fell 4.8% to close at $156.55 on Monday.
  • RBC Capital raised the price target for Cogent Communications Holdings, Inc. CCOI from $61 to $69. RBC Capital analyst Bora Lee maintained an Outperform rating on the stock. Cogent Communications shares fell 0.2% to close at $63.96 on Monday.
  • Mizuho lifted the price target for Group Limited TCOM from $45 to $49. Mizuho analyst James Lee maintained a Buy rating. shares fell 0.3% to close at $38.61 on Monday.
  • BTIG cut the price target for Aclaris Therapeutics, Inc. ACRS from $32 to $29. BTIG analyst Julian Harrison maintained a Buy rating. Aclaris Therapeutics shares fell 2.4% to $6.90 in pre-market trading.
  • Needham cut Cara Therapeutics, Inc. CARA price target from $26 to $22. Needham analyst Joseph Stringer maintained a Buy rating. Cara Therapeutics shares fell 27.6% to $7.25 in pre-market trading.
  • Barclays raised Ciena Corporation CIEN price target from $71 to $74. Barclays analyst Tim Long maintained an Overweight rating. Ciena shares rose 0.7% to $51.25 in pre-market trading.
  • Evercore ISI Group increased Linde plc LIN price target from $355 to $375. Evercore ISI Group analyst Stephen Richardson maintained an Outperform rating. Linde shares fell 0.9% to $354.83 in pre-market trading.
  • Atlantic Equities raised Merck & Co., Inc. MRK price target from $122 to $127. Atlantic Equities analyst Steve Chesney maintained an Overweight rating. Merck shares rose 0.1% to $111.12 in pre-market trading.
  • Credit Suisse raised Esperion Therapeutics, Inc. ESPR price target from $6.5 to $7. Credit Suisse analyst Judah Frommer upgraded the stock from Underperform to Neutral. Esperion Therapeutics shares fell 0.1% to $5.07 in pre-market trading.
  • Jefferies raised DocuSign, Inc. DOCU price target from $70 to $80. Jefferies analyst Brent Thill maintained a Buy rating. DocuSign shares fell 1.4% to close at $64.15 on Monday.
  • Wells Fargo raised Guidewire Software, Inc. GWRE price target $55 to $60. Wells Fargo analyst Michael Turrin maintained an Underweight rating. Guidewire Software shares fell 2.3% to close at $71.52 on Monday.

Check This Out: Insiders Selling Moderna, Hayward Holdings And 2 Other Stocks

Market News and Data brought to you by Benzinga APIs
Price Target
Posted In: NewsPrice TargetSmall CapPre-Market OutlookMarketsAnalyst RatingsTrading Ideasanalyst forecastsPT Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!